NCT00000304View on ClinicalTrials.gov

Dextroamphetamine as an Adjunct in Cocaine Treatment - 1

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

August 31, 1997

Primary Completion Date

August 31, 2001

Study Completion Date

August 31, 2001

Conditions
Cocaine-Related DisordersSubstance-Related Disorders
Interventions
DRUG

Dextroamphetamine

15 mg for first 8 weeks and 30 mg for 2nd 8 weeks

DRUG

D-Amphetamine

30 mg for the first 8 weeks and 60 for the second 8 weeks (16 weeks total)

DRUG

Placebo

Placebo

Trial Locations (1)

77225

University of Texas Health Science Center, Houston

All Listed Sponsors
collaborator

University of Texas

OTHER

lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00000304 - Dextroamphetamine as an Adjunct in Cocaine Treatment - 1 | Biotech Hunter | Biotech Hunter